Evicenter
MarkdownMedical informationP&T meetings
Envudeucitinib (ESK-001)

Moderate-to-severe plaque psoriasis

Also known as FTP-637
Manufacturer
Alumis
Launch
Not announced
Last updated
277 sources

Product information and disease descriptionProduct descriptionProduct informationPharmacology

Mechanism of action

5 evidence topics · 4 sources

Allosteric inhibition of TYK2 through the pseudokinase (JH2) domain
Human whole-blood inhibitory concentrations by cytokine pathway
Stimulus (kinase pathway)Human whole blood IC50 (nM)
IFNα (TYK2)“104”
IL-12 (TYK2)“149”
IL-2 (JAK1/JAK3)“>30,000”
TPO (JAK2)“>30,000”